APA Group reports strong full-year result: Is it time to buy?

A strong full-year result for APA Group (ASX:APA) could signal the start of a huge run, but is now the time to buy?

| More on:

You’re reading a free article with opinions that may differ from The Motley Fool’s Premium Investing Services. Become a Motley Fool member today to get instant access to our top analyst recommendations, in-depth research, investing resources, and more. Learn More

What? Hot on the heels of a record half year profit by Woodside Petroleum Limited (ASX: WPL), gas pipeline company APA Group (ASX: APA) has announced a strong full year result to 30 June 2014, with normalised Net Profit After Tax (NPAT) jumping 14%.

APA's revenues were driven 9.7% higher and helped by growing earnings from the company's expanded Mondarra Gas Storage Facility.

There are four key points for investors to note:

  • Normalised Net Profit After Tax up 14.0% to $199.6 million
  • Growth in the 'foreseeable future' fully funded
  • Total, full-year dividend 36.25 cps
  • Targeting normalised NPAT growth of 6-9% for FY15

So What?

The growth in earnings supported a slight 2.1% increase in full year dividend to 36.25 cents per share (cps). At the current share price ($7.74) that makes for a dividend yield of 4.7% (although it should be noted that shares went ex-dividend back on 26 June, 2014).

Importantly for investors, the distribution represents 68.9 per cent of normalised operating cash flow, leaving plenty to fund ongoing business growth.

APA Group is strongly positioned to take advantage of the increasing demand for natural gas transport in Australia as production grows in areas like the Cooper Basin.

Now What?

Does APA Group's result mean it's time to buy? The infrastructure-based business pairs up nicely with the needs of long-term conservative investors and the low risk cash-flows justify a slightly higher share price. However the current price of 32 times is too high for my liking.

APA is worth adding to your watchlist though. The company forecasts normalised EBITDA to be in the range of $740 million to $760 million for the full year 2015, an increase of up to 9% on FY14 and the dividend payment is expected to be "at least equal" to FY14.

Motley Fool contributor Regan Pearson does not own shares in any of the companies mentioned in this article.

More on ⏸️ Investing

A white and black robot in the form of a human being stands in front of a green graphic holding a laptop and discussing robotics and automation ASX shares
Technology Shares

Joining the revolution: How I'd invest in ASX AI shares right now

Advances in artificial intelligence (AI) could usher in a new industrial revolution. Here’s how you can invest in it.

Read more »

Close up of baby looking puzzled
Retail Shares

What has happened to the Baby Bunting (ASX:BBN) share price this year?

It's been a volatile year so far for the Aussie nursery retailer. We take a closer look

Read more »

woman holds sign saying 'we need change' at climate change protest
ETFs

3 ASX ETFs that invest in companies fighting climate change

If you want to shift some of your investments into more ethical companies, exchange-traded funds can offer a good option

Read more »

a jewellery store attendant stands at a cabinet displaying opulent necklaces and earrings featuring diamonds and precious stones.
⏸️ Investing

The Michael Hill (ASX: MHJ) share price poised for growth

Investors will be keeping an eye on the Michael Hill International Limited (ASX: MHJ) share price today. The keen interest…

Read more »

ASX shares buy unstoppable asx share price represented by man in superman cape pointing skyward
⏸️ Investing

The Atomos (ASX:AMS) share price is up 15% in a week

The Atomos (ASX: AMS) share price has surged 15% this week. Let's look at what's ahead as the company build…

Read more »

Two people in suits arm wrestle on a black and white chess board.
Retail Shares

How does the Temple & Webster (ASX:TPW) share price stack up against Nick Scali (ASX:NCK)?

How does the Temple & Webster (ASX: TPW) share price stack up against rival furniture retailer Nick Scali Limited (ASX:…

Read more »

A medical researcher works on a bichip, indicating share price movement in ASX tech companies
Healthcare Shares

The Aroa (ASX:ARX) share price has surged 60% since its IPO

The Aroa (ASX:ARX) share price has surged 60% since the Polynovo (ASX: PNV) competitor listed on the ASX in July.…

Read more »

asx investor daydreaming about US shares
⏸️ How to Invest

How to buy US shares from Australia right now

If you have been wondering how to buy US shares from Australia to gain exposure from the highly topical market,…

Read more »